Jeff Haywood
Managing Director · Spectrum Equity
Managing DirectorBoston, MA
Jeff Haywood is a managing director at Spectrum Equity in Boston, where he co-leads the firm's healthcare technology practice. He joined Spectrum in 2007 and was promoted to managing director in 2019, investing across providers, payers, life sciences and consumers. His healthcare exits include the IPOs of Definitive Healthcare and GoodRx and sales of Payer Compass and PWNHealth; he currently sits on the boards of RxVantage and VBA. Before Spectrum he was an associate at Thoma Cressey and an analyst at Goldman Sachs; he holds a BA from Duke.
Board seats
22 current
· PUBLIC SOURCES
Credited hits
7
· PUBLIC SOURCES
Midas years
LAST CHECKED NOV 2026
Founder rating
LAST CHECKED NOV 2026
Maintained from public sources. Not claimed. If you're Jeff Haywood, you can claim this profile.
Claim this profileHow claiming worksClaiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.
Track record
- Definitive Healthcareipo
Went public in September 2021 (NASDAQ: DH); listed among Jeff Haywood's healthcare exits on his Spectrum bio.
Source: spectrumequity.com
- GoodRxipo
Public offering; listed among Jeff Haywood's healthcare exits on his Spectrum bio.
Source: spectrumequity.com
- Payer Compassacquired
Strategic exit; listed among Jeff Haywood's exits on his Spectrum bio (acquired by Zelis).
Source: spectrumequity.com
- PWNHealthacquired
Acquired by Everlywell to form Everly Health; listed among Jeff Haywood's exits on his Spectrum bio.
Source: spectrumequity.com
- Datassentialacquired
Sold to a private equity consortium in 2024; listed among Jeff Haywood's exits on his Spectrum bio.
Source: spectrumequity.com
- Net Healthacquired
Financial sponsor liquidity event; listed among Jeff Haywood's exits on his Spectrum bio.
Source: spectrumequity.com
- Membersyacquired
Financial sponsor liquidity event; listed among Jeff Haywood's exits on his Spectrum bio.
Source: spectrumequity.com
Board seats
Current board seats · 2
- RxVantageSource: spectrumequity.com
- VBASource: spectrumequity.com
Success signals
Forbes Midas List
No public record
Not listed.
Reputation
No reputation score — basis not established for this investor.
No reputation sources on file yet.
Suggest a sourceContact
Published sources only
Published contact details collected from public sources. Not a referral, and not an introduction.
Published contact
- Website
- www.spectrumequity.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
Claimed profiles can replace or remove contact details.
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Jeff Haywood. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewFirm-level reviews are not attributed to Jeff Haywood.
Methodology
This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.
Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.
Corrections with a source: Suggest a correction.
Source record 1
- [1]
DATABASE · GlassVC catalog — Catalog record for Jeff Haywood — provenance: GlassVC catalog
↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals · Board seats
EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026
